|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Methylamine and dimethylamine photocatalytic degradation-Adsorption isotherms and kinetics显示文摘 | Helali S Puzenat E Perol N | 2011 | Applied Catalysis A:General2011，402，1： | 1 |
| 2 | Medroxyprogeste- rone,interferon alfa-2a, interleukin 2, or combination of both cytokines in patients with metastatic renal carcinoma of intermediate prognosis: results from a randomized controlled trial 显示文摘 | Negrier S Perol D Ravaud C | 2007 | Cancer2007，110，11： | 1 |
| 3 | On the relationshipbetween supplier integration and time-to-market显示文摘 | Perols J Zimmermann C Kortmann S | 2013 | Journal of Operations Management2013，31，3： | 1 |
| 4 | Heritability of adult body height:a comparative study of twin cohorts in eight countries显示文摘 | Silventoinen K Sammalisto S Perols M | | 0，，： | 1 |
| 5 | Lymphopenia as a prognostic factor for overall survival in advanced carcinomas,sarcomas,and lymphomas显示文摘 | Ray-Coquard I Cropet C Van Glabbeke M Sebban C Le Cesne A Judson I Tredan O Verweij J Biron P Labidi I Guastalla JP Bachelot T Perol D Chabaud S Hogendoorn PCW Cassier P Dufresne A Blay JY | 2009 | Cancer Res2009，69，13： | 1 |
| 6 | On the relationship between supplier integration and time- to-market显示文摘 | Perols J Zimmermann C Kortmann S | 2013 | Journal of Operations Management2013，31，3： | 1 |
| 7 | Randomized study of intravenous versus subcutaneous interleukin-2, and IFN alpha in patients with good prognosis metastatic renal cancer 显示文摘 | Negrier S Perol D Ravand A | 2008 | Clin Cancer Res2008，14，18： | 1 |
| 8 | Carcinomatous lymphangitis 显示文摘 | Hominal S Farchero L Perol M | 1999 | Prrese Med1999，28，18： | 1 |
| 9 | lnterleukin-60 interleukin-10, and vascular endothelial growth factor in metastatic renal call carcimona: prognostic value of interleukin-6 from the Groupe Francais d'Immunotherapie 显示文摘 | Negrier S Perol D Menetrier-Caux C | 2004 | J Clin Oncolo2004，22，： | 1 |
| 10 | Mathylamine and dimethylamine photocatalytic degradation-Adsorption isotherms and kinetics显示文摘 | Helali S Puzenat E Perol N | 2011 | Applied Catalysis A : General2011，402，12： | 1 |
| 11 | Cortical control of a prosthetic arm for self-feeding 显示文摘 | Velliste M Perol S Spalding MC | 2008 | Nature2008，453，7198： | 1 |
| 12 | Do cytokines improve survival inpatients with metastatic renal cell carcinoma of intermediate progno-sis?Results of the prospectively randomized PERCY Quattro trial显示文摘 | Negrier S Perol D Ravaud C | 2005 | Am Soc Clin Oncol Proc2005，4，： | 1 |
| 13 | Acute diffuse interstitial pneumopathy followingdocetaxel (Taxotere) - apropos of 2 cases显示文摘 | Etienne B Perol M Nesme P Vuillermoz S Robinet G Guerin JC | 1998 | Rev Mai Respir1998，15，2： | 1 |
| 14 | Medroxypmgesterone, interferon alpha-2a, interleukin 2, or combination of both cytokines in patients with metastatic renal carcinoma of intermediate prognosis : results of a randomized controlled trial 显示文摘 | Negrier S Perol D Ravaud A | 2007 | Cancer2007，110，11： | 1 |
| 15 | On the Relationship between Supplier Integration and Time-to-Market显示文摘 | Perols J Zimmermann C Kortmann S | 2013 | Journal of Operations Management2013，31，3： | 1 |
| 16 | Interleukin-6 interleukin-10, and vascular metastatic renal cell carcinoma endothelial growth factor in prognostic value of interleukin-6 from the Groupe Francais d'Immunotherapie显示文摘 | Negrier S Perol D Menetrier-Caux C | 2004 | J Clin Oncol2004，22，： | 1 |
| 17 | Medroxyprogest- erone, interferon alfa-2a, interleukin 2, or combination of both cytokines in patients with metastatic renal carci- noma of intermediate prognosisl results of a random- ized controlled trial显示文摘 | Negrier S Perol D Ravaud A | 2007 | Cancer2007，110，11： | 1 |
| 18 | Mathylamine and dimethylamine photocatalytic degradation-adsorption isoth- erms and kinetics显示文摘 | Helali S Puzenat E Perol N | 2011 | Applied Catalysis A : General2011，402，： | 1 |
| 19 | Temsirolimus and bevacizumab, or sunitinib, or interferon alfa and bevacizumab for patients with advanced renal cell carcinoma (TORAVA): a randomised phase 2 trial显示文摘 | Negrier S Gravis G Perol D | 2011 | Lancet Oncol2011，12，7： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员